News

News Archive

Boehringer Ingelheim R&D pushes to transcend disease boundaries Boehringer Ingelheim R&D pushes to transcend disease boundaries

Promising first-in-class and potential medical breakthrough pipeline projects presented at R&D Press Conference• 80 clinical and pre-clinical projects of which 65% have first-in-class and breakthrough potential • Highlight: First-in-class monoclonal antibody shows potential in multiple inflammatory diseases• 15 new medicines could potentially be approved by 2025 in immunology, CNS, oncology, respiratory and cardiometabolic diseases

Evox Therapeutics expands into new facilities at The Oxford Science Park Evox Therapeutics expands into new facilities at The Oxford Science Park

Expansion significantly increases laboratory space, creating new job opportunities in the area

By Royal approval: Queen’s Award success for Elucigene By Royal approval: Queen’s Award success for Elucigene

Pioneering medical technology company, Elucigene Diagnostics, has been awarded the UK’s most prestigious honour for outstanding success in international trade: the Queen’s Award for Enterprise.

The May issue of Drug Discovery Today is a Special Issue and will be published very soon The May issue of Drug Discovery Today is a Special Issue and will be published very soon

The latest issue of Drug Discovery Today will soon be published very soon. It is a Special Issue on Novel Nanotherapeutic Strategies: Fabrication Approaches, Application and Clinical Challenges

Making great drugs – only half the battle? Making great drugs – only half the battle?

This month’s “The View from Here” deals with the field of oncology; great advances have been made, especially with respect to immuno oncology. Brilliant new drugs are becoming available, it would seem, every day. But is that everything? Do we lose sight of the patient?

Dundee scientists solve 3D structure of key protein involved in Intellectual Disability Dundee scientists solve 3D structure of key protein involved in Intellectual Disability

Scientists at the University of Dundee have identified the effects of a mutation that gives rise to a form of Intellectual Disability

Molecular details of protein crystal nucleation uncovered Molecular details of protein crystal nucleation uncovered

A team of researchers led by Dr. Mike Sleutel from the VIB-VUB Center for Structural Biology in collaboration with scientists from the Institute for Complex Molecular Systems of the Eindhoven University of Technology, and the CNRS in Grenoble, have for the first time uncovered the molecular details of protein crystal nucleation, a process with great medical and scientific relevance. The team also developed a new methodology to study a broad class of systems that have remained elusive to date. Their results are published in Nature.

Elsevier launches Mendeley Data Elsevier launches Mendeley Data

Elsevier, the information analytics business specializing in science and health, has launched Mendeley Data, a new, cloud-based platform designed to help universities and researchers manage, share and showcase their research data.